EC 35 (Atelvia risedronate sodium delayed-release 35 mg)
Generic Name: risedronate
Pill imprint EC 35 has been identified as Atelvia risedronate sodium delayed-release 35 mg.
Atelvia is used in the treatment of osteoporosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Atelvia risedronate sodium delayed-release 35 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- EC 35
- risedronate sodium delayed-release 35 mg
- Prescription only
- Drug Class:
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Warner Chilcott Laboratories
- National Drug Code (NDC):
- Inactive Ingredients:
- edetate disodium
ferric oxide yellow
methacrylic acid - ethyl acrylate copolymer (1:1) type a
sodium starch glycolate type A potato
|NDC Code||Manufacturer / Repackager|
|00591-3876||Watson Pharmaceuticals, Inc.|
Note: Inactive ingredients may vary.
More about Atelvia (risedronate)
- Other brands: Actonel
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.